SCHEMBL23197652

SCHEMBL23197652

CCCC[C@H](C)C(=N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8296936 1.00
Hydrochloric Acid SCHEMBL1229520 0.98 CA1 (0.40)
SCHEMBL27863219 0.93 CA1 (0.50)
SCHEMBL10185778 0.91 SPHK1 (0.48)
SCHEMBL172831 0.91 SPHK1 (0.48)
SCHEMBL12566014 0.91 SPHK1 (0.48)
SCHEMBL2698591 0.91 SPHK1 (0.48)
SCHEMBL172766 0.91 SPHK1 (0.48)
SCHEMBL28842476 0.91 SPHK1 (0.48)
SCHEMBL18464396 0.91 SPHK1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024073042-A1 OCULAR DELIVERY OF THERAPEUTIC AGENTS ENTRADA THERAPEUTICS, INC. (US) 2024-04-04 WO disclosed
WO-2021064142-A1 HETEROCYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OR AMELIORATION OF CANCER TOLREMO THERAPEUTICS AG (CH) 2021-04-08 WO disclosed